Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 11Breast 11Other hematologic neoplasm 10Other solid neoplasm 9Thoracic 8Gastrointestinal 7Lymphoid 5Head & Neck 5Gynecologic 4Dermatologic 4Tumor-Agnostic 3CNS 3Sarcoma 1Plasma cell 1Other 1Myeloid 1

Conditions

Sarcoma 1

Interventions

Specimen Handling 38Magnetic Resonance Spectroscopy 32Cyclophosphamide 27Doxorubicin 24Temozolomide 23Biopsy 23pembrolizumab 22Radiotherapy 19X-Rays 18Radiation 18Nivolumab 16Vincristine 14Irinotecan 13Phantoms, Imaging 12Ifosfamide 12Gemcitabine 11fludarabine 10cabozantinib 10atezolizumab 10Ipilimumab 10Bevacizumab 9liposomal doxorubicin 8Paclitaxel 8Immunoglobulin G 8Surgical Procedures, Operative 7Dactinomycin 7Carboplatin 7palbociclib 6olaparib 6durvalumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Practice Guidelines as Topic × Sarcoma × 90 days × Clear all
NCT05216029 2026-04-01

Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma

M.D. Anderson Cancer Center

Phase NA Completed
92 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡